General Catalyst Group Management’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

General Catalyst Group Management’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,311,624	Closed	-$23.1M	–	15
2022 Q3	$23.1M	Hold	2,311,624	–	–	2.13%	8
2022 Q2	$22.8M	Hold	2,311,624	–	–	2.03%	10
2022 Q1	$22.8M	Hold	2,311,624	–	–	1.29%	12
2021 Q4	$22.6M	Hold	2,311,624	–	–	0.86%	12
2021 Q3	$22.6M	Buy	2,311,624 +87,500	+4%	+$857K	1.15%	11
2021 Q2	$22.3M	Buy	+2,224,124	New	+$22.7M	0.96%	9

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

General Catalyst Group Management's HAAC Position: Q4 2022 in Review

General Catalyst Group Management sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 2,311,624 shares — an estimated $23.1M sold.

General Catalyst Group Management first reported a position in HAAC in Q2 2021 and held it in 6 quarters. The position peaked at $23.1M in Q3 2022. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

General Catalyst Group Management reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
General Catalyst Group Management sold 2,311,624 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $23.1M.
General Catalyst Group Management first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 6 quarters.
General Catalyst Group Management's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $23.1M in Q3 2022.
1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on General Catalyst Group Management's 13F filing for Q4 2022, filed 15 Feb 2023.